Share Buyback

After a year of declines, home prices are leveling off, creating a rare window of opportunity for buyers with more choice and negotiating power.

Activist investor Oasis challenges Kao's ethics, citing forced labor links and a recent ESG downgrade, pushing for an independent supply chain probe.

With assets double its market value, Base Carbon's CEO claims it's no junior firm. A deep dive into its finances and high-integrity carbon projects.

The EdTech firm reports a 63% surge in free cash flow, leveraging AI innovation to offset headwinds from a cooling U.S. K-12 market.

With its pure-play chemical transition complete, Ascent adds two heavyweights to its board, signaling an aggressive new phase of growth and M&A.

A new report reveals a huge gap between patient desires for holistic, less invasive fertility options and a system that defaults to costly IVF treatments.

The optics giant posted record revenue and soaring profits, yet its stock is near a 52-week low. The market sees a smartphone slump; Sunny sees a future in AI.

The conglomerate's massive impairment signals a strategic pivot to shed legacy assets and double down on its high-growth core businesses in pharma and tourism.

As The Hanover prepares its Q1 2026 report, investors watch to see if it can sustain momentum amid inflation, high rates, and catastrophe risks.

Canadian explorer BluEnergies begins trading on OTCQX, aiming to leverage U.S. capital for its ambitious oil projects in West Africa and the Gulf of Mexico.

Chinese pet platform Boqii slashes losses by 75% despite falling revenue, betting its future on high-margin private labels and operational discipline.

LM Funding reports higher revenue and record Bitcoin mining but a staggering $17.9M Q4 loss reveals the harsh reality of crypto market swings.

Neutech Group builds on its education, healthcare, and wellness strategy, but a closer look at its 2025 financials reveals a more complex picture.

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.

A troubled mortgage firm is paying shareholders while under a trade ban, revealing a portfolio in distress and raising red flags for Canada's lending sector.

As Milestone Scientific prepares its year-end call, investors look for signs of a turnaround and growth for its advanced injection technology.

GrafTech's major price increase on a key steelmaking component signals a market shift, putting new pressure on electric arc furnace steel producers.

Strong product sales and innovation clash with a steep service decline in Europe, forcing Enerpac to restructure and adjust its outlook for 2026.

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

OTC-listed APPlife Digital Solutions is launching weekly investor calls, a bold move to build trust. But can it overcome its financial hurdles?